Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Clinical trial NCT00122681 · COMPLETED

Trial details

NCT number: NCT00122681
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2004-05-06
Primary completion: 2006-11-03
Enrollment: 18729

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.